Prothena Corp.

Prothena Corp.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
35.03 M
Public Float
-

Profile

Address
77 Sir John Rogersons Quay
Dun Laoghaire Dublin 2
Ireland
Employees -
Website http://www.prothena.com
Updated 07/08/2019
Prothena Corp. Plc is a late-stage clinical biotechnology company, which research, development and commercialization of therapies in the neuroscience and orphan categories. Its antibody-based product candidates target a potential indications including amyloidosis and Parkinson's disease. The company was founded on December 20, 2012 and is headquartered in Dun Laoghaire, Ireland.

Financials

View All
Created with Highcharts 5.0.14Prothena Corp.Net Income. Fiscal year is January-December. All values USD Thousands.40 99640 9967 1507 15080 61280 612160 108160 108153 237153 237155 645155 645201320142015201620172018050k100k150k200k
Created with Highcharts 5.0.14Prothena Corp.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.67667650 85450 8541 6071 6071 0551 05527 51927 519955955201320142015201620172018010k20k30k40k50k60k

Gene G. Kinney
President, Chief Executive Officer & Director
Lars G. Ekman
Chairman